Respiri's Patient Programs Show 'Significant' Reduction in Hospitalizations; Shares Up 5%

MT Newswires Live

Oct 07, 2024

Respiri's (ASX:RSH) patient programs showed a "significant" reduction in hospitalizations and emergency room visits, accelerating discussions with new and existing clients, according to a Friday filing with the Australian bourse.

The programs registered a 56% decline in rehospitalizations and a 47% drop in emergency room visits.

The medical devices company is in advanced contract discussions with new potential clients as it increases revenues for existing partner Ceras' clients by 51%, to $74 from around $49 per patient per month, and increased the number of monthly reimbursed services to patients to 1.4 from around 1, the filing stated.

The company's shares jumped 5% in recent Monday trade.

Price (AUD): $0.04, Change: $+0.002, Percent Change: +5.00%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2473511390"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2473511390\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2473511390?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-07 08:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2473511390","market":"sh","top_or_hot":-1,"title":"Respiri's Patient Programs Show 'Significant' Reduction in Hospitalizations; Shares Up 5%","media":"MT Newswires Live","content":"<html><body><p> Respiri's (ASX:RSH) patient programs showed a \"significant\" reduction in hospitalizations and emergency room visits, accelerating discussions with new and existing clients, according to a Friday filing with the Australian bourse.</p><p>The programs registered a 56% decline in rehospitalizations and a 47% drop in emergency room visits.</p><p>The medical devices company is in advanced contract discussions with new potential clients as it increases revenues for existing partner Ceras' clients by 51%, to $74 from around $49 per patient per month, and increased the number of monthly reimbursed services to patients to 1.4 from around 1, the filing stated.</p><p>The company's shares jumped 5% in recent Monday trade.</p><p>Price (AUD): $0.04, Change: $+0.002, Percent Change: +5.00%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Respiri's Patient Programs Show 'Significant' Reduction in Hospitalizations; Shares Up 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRespiri's Patient Programs Show 'Significant' Reduction in Hospitalizations; Shares Up 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-07 08:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Respiri's (ASX:RSH) patient programs showed a \"significant\" reduction in hospitalizations and emergency room visits, accelerating discussions with new and existing clients, according to a Friday filing with the Australian bourse.</p><p>The programs registered a 56% decline in rehospitalizations and a 47% drop in emergency room visits.</p><p>The medical devices company is in advanced contract discussions with new potential clients as it increases revenues for existing partner Ceras' clients by 51%, to $74 from around $49 per patient per month, and increased the number of monthly reimbursed services to patients to 1.4 from around 1, the filing stated.</p><p>The company's shares jumped 5% in recent Monday trade.</p><p>Price (AUD): $0.04, Change: $+0.002, Percent Change: +5.00%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2473511390","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473511390","pubTimestamp":1728259317,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Respiri's  patient programs showed a \"significant\" reduction in hospitalizations and emergency room visits, accelerating discussions with new and existing clients, according to a Friday filing with the Australian bourse.The programs registered a 56% decline in rehospitalizations and a 47% drop in emergency room visits.The medical devices company is in advanced contract discussions with new potential clients as it increases revenues for existing partner Ceras' clients by 51%, to $74 from around $49 per patient per month, and increased the number of monthly reimbursed services to patients to 1.4 from around 1, the filing stated.The company's shares jumped 5% in recent Monday trade.Price : $0.04, Change: $+0.002, Percent Change: +5.00%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","BK7503":"科技股","BK7007":"医疗保健设备","BK4125":"广播"},"translate_title":"Respiri的患者计划显示住院人数“显着”减少；股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSH.AU":0.9,"AUD":1},"content_text":"Respiri's (ASX:RSH) patient programs showed a \"significant\" reduction in hospitalizations and emergency room visits, accelerating discussions with new and existing clients, according to a Friday filing with the Australian bourse.The programs registered a 56% decline in rehospitalizations and a 47% drop in emergency room visits.The medical devices company is in advanced contract discussions with new potential clients as it increases revenues for existing partner Ceras' clients by 51%, to $74 from around $49 per patient per month, and increased the number of monthly reimbursed services to patients to 1.4 from around 1, the filing stated.The company's shares jumped 5% in recent Monday trade.Price (AUD): $0.04, Change: $+0.002, Percent Change: +5.00%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}